GHAPPcast: Biosimilars Unveiled: Empowering APPs for Better Patient Conversations
GHAPPcast21 Elo 2024

GHAPPcast: Biosimilars Unveiled: Empowering APPs for Better Patient Conversations

Thank you to Boehringer Ingelheim for your support of this podcast.

In this episode of GHAPPcast, the official podcast for Gastroenterology and Hepatology Advanced Practice Providers, host Gabriella McCarty, NP, is joined by Tedra Gray, NP, to explore the role of biosimilars in GI treatment. They dive into the differences between biosimilars and generics, the cost savings associated with biosimilars, their safety and efficacy, and strategies for effectively educating patients about making the switch. With insights into the FDA approval process, insurance challenges, and real-world clinical experience, this discussion provides essential guidance for APPs looking to enhance patient care and communication.

Key topics covered include what biosimilars are and how they differ from generics, the benefits of switching to a biosimilar—including improved access and cost savings—how biosimilars are tested for safety and efficacy, and best practices for discussing these treatments with patients. The episode also addresses common patient concerns, potential barriers to biosimilar adoption, and how to navigate insurance requirements.

To stay informed, visit ghapp.org for more resources or download the GHAPP ACE app. Don’t forget to subscribe to GHAPPcast for more expert insights into gastroenterology and hepatology. Tune in now to gain valuable knowledge that will help you empower your patients and improve their treatment experience.

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(164)

Linerixibat Medication Review

Linerixibat Medication Review

Christina Hanson, FNP, and Dr. Marcelo Kugelmas of South Denver Gastroenterology review linerixibat, an ileal bile acid transporter (IBAT) inhibitor, and its role in managing cholestatic pruritus in p...

22 Syys 13min

Podcast: Managing Fatigue and Pruritus in Your Patients With PBC

Podcast: Managing Fatigue and Pruritus in Your Patients With PBC

How can clinicians better recognize and manage itching and fatigue in primary biliary cholangitis (PBC)? In this podcast, hepatology clinicians from RUSH University Medical Center discuss the impact o...

15 Syys 15min

Podcast: How to Screen and Diagnose Cholestatic Liver Diseases

Podcast: How to Screen and Diagnose Cholestatic Liver Diseases

In this episode, HoChong Gilles of the Richmond VA Medical Center, and Alison Moe of Atlanta Gastroenterology discuss a practical, step-by-step approach to screening for and diagnosing cholestatic liv...

25 Elo 20min

GHAPPcast: Recognizing and Managing Overt Hepatic Encephalopathy

GHAPPcast: Recognizing and Managing Overt Hepatic Encephalopathy

Thank you to Salix for their support on this podcast episode. In this GHAPP podcast, host Christina Hanson, FNP, welcomes Janet Gripshover, DNP, FNP-BC, MBA, for a practical discussion on recognizing ...

18 Elo 48min

FAQ: Counseling Patients on Overt Hepatic Encephalopathy

FAQ: Counseling Patients on Overt Hepatic Encephalopathy

Thank you to Salix for their support on this FAQ video module.In this FAQ video module, Natalie Oliver, PA-C, discusses how healthcare professionals can counsel patients and caregivers about overt hep...

11 Elo 4min

FAQ: Identifying & Diagnosing Overt Hepatic Encephalopathy

FAQ: Identifying & Diagnosing Overt Hepatic Encephalopathy

Thank you to Salix for their support on this FAQ video module. In this FAQ video module, Samantha Ramirez, NP-C, discusses how healthcare professionals can identify and diagnose overt hepatic encephal...

4 Elo 2min

Subgroup Analysis: Differences in Maintenance Dosing For UC and CD

Subgroup Analysis: Differences in Maintenance Dosing For UC and CD

Thank you to Johnson & Johnson for their support on this podcast episode. In this GHAPP podcast, Amy Stewart, NP, of Capital Digestive Care, introduces a practical inflammatory bowel disease discussio...

23 Heinä 7min

Medication Review: Efficacy & Safety of Risankizumab in Patients with Moderate to Severely Active UC

Medication Review: Efficacy & Safety of Risankizumab in Patients with Moderate to Severely Active UC

Thank you to AbbVie for their support of this Medication Review Video Module.In this medication review, Melissa Ferrari, PA, and Jennifer Hamilton, MSPAS, PA-C, provide a comprehensive overview of the...

30 Kesä 17min

Suosittua kategoriassa Terveys ja hyvinvointi

unicast
aamukahvilla
psykopodiaa-podcast
vakeva-elama-viisaampi-mieli-vahvempi-keho
meditaatiot-suomeksi
rss-kuumilla-aalloilla
tiedenaiset-podcast
rss-pitaisko-erota
rss-pt-paahtio
voi-hyvin-meditaatiot-2
rss-uplevel-by-sonja-hannus
rss-duodecim-lehti
rss-hereilla
selviytyjat-tarinoita-elamasta
rss-palaudu-synnytyksesta-podcast
rss-terapiaklubi
junnut-pelissa
rss-kehtaanko-kysya-podcast-aideille
rss-mighty-finland-podcast
terapiassa